BIOMAT Database Logo BIOMAT Database Logo

Effects of renal disease upon drug disposition. 1978

M M Reidenberg, and D E Drayer

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

M M Reidenberg, and D E Drayer
Effects of liver disease on drug disposition in man.
December 1976, Biochemical pharmacology,
M M Reidenberg, and D E Drayer
Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
January 2019, Advances in experimental medicine and biology,
M M Reidenberg, and D E Drayer
Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity.
August 2012, Current protocols in toxicology,
M M Reidenberg, and D E Drayer
Oxaprozin disposition in renal disease.
April 1982, Clinical pharmacology and therapeutics,
M M Reidenberg, and D E Drayer
Drug transporters and renal drug disposition in the newborn.
January 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
M M Reidenberg, and D E Drayer
Liver disease and drug disposition.
May 1992, British journal of anaesthesia,
M M Reidenberg, and D E Drayer
Drug disposition in liver disease.
December 1982, American family physician,
M M Reidenberg, and D E Drayer
Drug disposition and liver disease.
January 1975, Drug metabolism reviews,
M M Reidenberg, and D E Drayer
Drug disposition in liver disease.
June 1977, The New England journal of medicine,
M M Reidenberg, and D E Drayer
Pharmacogenomics--drug disposition, drug targets, and side effects.
February 2003, The New England journal of medicine,
Copied contents to your clipboard!